NHS England Halts Puberty Blockers for Transgender Youth

England's National Health Service (NHS) has ceased prescribing puberty blockers for children and young people with gender dysphoria, citing insufficient evidence of safety and clinical effectiveness. The decision, condemned by LGBTQ groups, limits access to puberty blockers to clinical research trials and some private clinics, sparking criticism and concern from advocates. Meanwhile, in the US, major medical associations support gender-affirming care for trans youth, including the use of puberty blockers, emphasizing its potential life-saving impact.